DA32 Life Science Tech Acquisition Corp. (DALS) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Steven Kafka.
DALS を有する IPO日 2021-07-28, に上場 NASDAQ Capital Marke, 時価総額 $264.2M.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
